Note: Ingredients listed on restricted chemical lists
EC/CAS
119-36-8
Name of the chemical
Methyl salicylate
Concentration
16.5
EC/CAS
89-78-1
Name of the chemical
Menthol; dl-menthol; l-menthol; d-menthol (40)
Concentration
3.3
EC/CAS
122-99-6
Name of the chemical
2-Phenoxyethanol
Concentration
0.75
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
0.1
General Information
Revision date
2022-03-09
Product name
IODEX HERBAL GEL (MFC70131)
Product Synonyms
PROJECT IODEX HERBAL GEL * MFC70131 (MFR/EXT/024) * KUNDURU NIRYASA
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Serious eye damage/eye irritation Category 1 Sensitization, skin Category 1
Environmental hazards
Hazardous to the aquatic environment, Category 3
Long term hazards
OSHA defined hazards Not classified.
Signal word
Danger
Hazard statements
May cause an allergic skin reaction. Causes serious eye damage. Harmful to aquatic life with long lasting effects.
Prevention
Avoid breathing mist/vapors. Contaminated work clothing must not be allowed out of the workplace. Avoid release to the environment. Wear eye protection/face protection. Wear protective gloves.
Response
If on skin Wash with plenty of water/. If in eyes Rinse cautiously with water for several minutes Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a poison center/doctor/. Specific treatment (see instruction on this label). If skin irritation or rash occurs: Get medical advice/attention. Wash contaminated clothing before reuse.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
7% of the mixture consists of component(s) of unknown acute oral toxicity. 10.85% of the mixture consists of component(s) of unknown acute dermal toxicity. 5.5% of the mixture consists of component(s) of unknown acute inhalation toxicity. 7% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 5.5% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
